| Literature DB >> 28545438 |
Baidya Nath Jha1,2, Mitesh Shrestha1,2, Durga Prasad Pandey3, Tribikram Bhattarai2, Hari Datta Bhattarai1, Babita Paudel4.
Abstract
BACKGROUND: Several lichen species are reported to be used tradiationally in many theraupatic practices. Many lichen species are reported as sources of several bioactive natural compounds. Several lichen species of Nepal are so far chemically unexplored.Entities:
Keywords: Antimicrobial; Antioxidant; DPPH; Lichen; Thin layer chromatography
Mesh:
Substances:
Year: 2017 PMID: 28545438 PMCID: PMC5445338 DOI: 10.1186/s12906-017-1797-x
Source DB: PubMed Journal: BMC Complement Altern Med ISSN: 1472-6882 Impact factor: 3.659
Lichens collected from Annapurna conservation area and their biological activities
| S.N | Symbol | Name | Dry wt. | Activity DPPHa | Anti microbial activity | Brine shrimp |
| ||
|---|---|---|---|---|---|---|---|---|---|
| Methanol | DCM | DCM | MeOH | DCM | DCM fraction | ||||
| 1 | DAN-1 |
| 10 | 44.4 ± 0.5 | 11.4 ± 0.1 | Α (7) B (7) | S | S | - |
| 2 | DAN-2 |
| 10 | - | - | - | S | S | - |
| 3 | DAN-3 |
| 10 | - | 22.9 ± 0.7 | Β(12) | S | S | - |
| 4 | DAN-4 |
| 2 | - | - | Β(11) | I | S | - |
| 5 | DAN-5 |
| 10 | - | - | A(10) B(10) | S | S | - |
| 6 | DAN-6 |
| 10 | 23.3 ± 0.3 | 22.1 ± 0.1 | A(10) B(9) | S | S | - |
| 7 | DAN-7 |
| 10 | - | - | Β (7) | I | S | - |
| 8 | DAN-8 |
| 9.1 | - | 44.1 ± 0.3 | Β (8) | W | S | - |
| 9 | DAN-9 |
| 10 | - | - | Β (7) | I | S | - |
| 10 | DAN-10 |
| 10 | - | - | Β (7) | I | S | - |
| 11 | DAN-11 |
| 3.6 | 11.3 ± 0.2 | 19.6 ± 0.1 | - | I | S | -- |
| 12 | JOM-1 |
| 10 | - | - | - | S | S | - |
| 13 | JOM -2 |
| 10 | - | - | Α(8) B (11) | S | S | - |
| 14 | JOM -3 |
| 10 | - | - | - | S | S | - |
| 15 | JOM -4 |
| 10 | - | - | Β(14) | S | S | - |
| 16 | JOM -5 |
| 10 | - | - | Β(10) | S | S | - |
| 17 | JOM -6 |
| 9.2 | 11.2 ± 0.1 | - | - | S | S | - |
| 18 | JOM -7 |
| 10 | - | - | - | I | S | 12 |
| 19 | JOM -8 |
| 10 | - | - | Α(11) B(7) | S | S | - |
| 20 | JOM -9 |
| 10 | - | - | - | W | I | - |
| 21 | JOM -10 |
| 5.9 | - | - | - | S | I | - |
| 22 | JOM -11 |
| 5.6 | - | - | Β(10) | I | S | - |
| 23 | JOM -12 |
| 10 | - | - | Α(12)B(13) | I | S | - |
| 24 | JOM -13 |
| 10 | - | - | Α(11)B(7) | S | S | 14 |
| 25 | JOM -14 |
| 2.8 | - | 49.9 ± 2.4 | Α(9)B(8) | I | S | 11 |
| 26 | JOM -15 |
| 3.8 | - | 47.7 ± 0.5 | Α(8)B(9) | I | S | - |
| 27 | JOM -16 |
| 0.9 | - | 47.1 ± 1.8 | - | I | W | - |
| 28 | CHA-1 |
| 10 | - | 20.2 ± 0.2 | - | I | S | - |
| 29 | CHA-2 |
| 10 | - | - | - | S | I | - |
| 30 | CHA-3 |
| 10 | - | - | - | S | S | - |
| 31 | CHA-4 |
| 0.8 | - | - | - | I | S | - |
| 32 | CHA-5 |
| 10 | - | - | - | I | S | - |
| 33 | CHA-6 |
| 9 | - | - | - | S | S | - |
| 34 | CHA-7 |
| 6.8 | - | - | - | S | I | - |
| 35 | CHA-8 |
| 10 | 5.7 ± 0.02 | 5.56 ± 0.2 | - | I | S | - |
| 36 | CHA-9 |
| 10 | - | - | - | I | W | - |
| 37 | GHAN-1 |
| 3.4 | - | - | - | I | I | - |
| 38 | GHAN-2 |
| 10 | - | - | Β(7) | S | S | - |
| 39 | GHAN-3 |
| 10 | - | - | Β(7) | W | S | - |
| 40 | GHAN-4 |
| 10 | - | - | Β(9) | I | S | - |
| 41 | GHAN-5 |
| 10 | 22.4 ± 0.9 | 44.6 ± 1.0 | Β(13) | S | S | - |
| 42 | GHAN-6 |
| 10 | - | - | Β(9) | I | S | - |
| 43 | GHAN-7 |
| 10 | - | - | - | S | S | - |
| 44 | GHAN-8 |
| 10 | 43.9 ± 2.1 | 47.3 ± 0.6 | - | S | S | - |
| 45 | GHAN-9 |
| 3 | 22.8 ± 0.9 | - | Β(12) | W | S | - |
| 46 | GHAN-10 |
| 8.5 | - | - | - | W | I | - |
| 47 | GHAN-11 |
| 10 | - | - | Β(12) | S | S | - |
| 48 | GHAN-12 |
| 10 | - | - | Β(9) | S | S | - |
| 49 | GHAN-13 |
| 10 | 19.9 ± 3.0 | - | Β(11) | I | S | - |
| 50 | GHAN-14 |
| 1.7 | - | - | - | I | I | - |
| 51 | GHAN-15 |
| 10 | - | 23.7 ± 0.1 | - | I | S | -- |
| 52 | GHAN-16 |
| 6.9 | - | - | Β(15) | S | S | - |
| 53 | GHAN-17 |
| 1.8 | - | - | - | S | S | - |
| 54 | GHAN-18 |
| 10 | - | - | Α(7)B(7) | I | S | - |
| 55 | GHAN-19 |
| 10 | - | - | Β(11) | S | S | - |
| 56 | GHAN-20 |
| 10 | - | - | Α(11)B(10) | S | S | - |
| 57 | GHAN-21 |
| 10 | - | - | Β(9) | I | S | - |
| 58 | SAR-1 |
| 7.8 | 21.2 ± 0.3 | 24.0 ± 0.1 | Β(8) | S | S | - |
| 59 | SAR-2 |
| 10 | - | - | Β(9) | S | S | - |
| 60 | SAR-3 |
| 7.83 | - | - | - | I | S | - |
| 61 | SAR-4 |
| 9.6 | - | - | - | S | S | - |
| 62 | SAR-5 |
| 5.3 | - | 49.0 ± 2.3 | Β(12) | S | S | - |
| 63 | SAR-6 |
| 10 | - | 50.7 ± 2.2 | Β(7) | W | S | - |
| 64 | SAR-7 |
| 10 | - | - | Β(7) | W | S | - |
| 65 | SAR-8 |
| 10 | - | - | Β(12) | W | S | - |
| 66 | SAR-9 |
| 10 | 87.3 ± 7.1 | - | Β(10) | W | S | - |
| 67 | SAR-10 |
| 10 | - | - | Β(8) | S | S | - |
| 68 | SAR-11 |
| 10 | 23.5 ± 0.8 | - | - | I | S | - |
| 69 | SAR-12 |
| 5.7 | - | 53.1 ± 6.9 | - | S | S | - |
| 70 | SAR-13 |
| 10 | 47.8 ± 1.3 | - | Α(9) | S | S | - |
| 71 | SAR-14 |
| 10 | - | - | Α(10)B(11) | I | S | - |
| 72 | SAR-15 |
| 3.5 | 49.8 ± 0.1 | - | Β(9) | M | S | - |
| 73 | SAR-16 |
| 1.5 | - | - | Β(8) | S | S | - |
| 74 | SAR-17 |
| 6 | - | - | Α(7) | M | S | - |
| 75 | SAR-18 |
| 8.6 | 49.9 ± 0.3 | - | - | S | S | - |
| 76 | SAR-19 |
| 8.4 | - | - | Α(9) | S | S | - |
| 77 | SAR-20 |
| 10 | - | - | Α(8) | W | S | - |
| 78 | SAR-21 |
| 7.3 | - | - | - | I | I | - |
| 79 | SAR-22 |
| 10 | - | - | - | S | S | - |
| 80 | SAR-23 |
| 6.4 | - | 24.1 ± 0.4 | - | W | S | - |
| 81 | SAR-24 |
| 1.2 | - | 45.8 ± 1.1 | Α(9) | I | S | - |
| 82 | SAR-25 |
| 0.6 | - | 47.9 ± 0.2 | - | I | S | - |
| 83 | SAR-26 |
| 1.4 | - | 46.7 ± 1.3 | Β(13) | I | S | - |
| 84 | SAR-27 |
| 0.4 | 49.3 ± 2.6 | - | Β(12) | I | S | - |
| BHA | 5.0 ± 0.4 | ||||||||
| Ampicillin(10 μg) | A(20),B(19) | ||||||||
| Amphotericin B(10 μg) | 20 | ||||||||
| Berberine chloride (8 μg) | W | ||||||||
| Berberine chloride (12 μg) | M | ||||||||
| Berberine chloride (16 μg) | S | ||||||||
aIC50 (50% inhibition in DPPH color) data, A-antibacterial active against Staphylococcus aureus (inhibition zone in mm), B-antibacterial activity against Klebsiella pneumoniae (inhibition zone in mm), S-strong activity (more than 80% death of brine shrimp), M-Moderate(50%–80% of death of brine shrimp), W-Weak (less than 50% of death of brine shrimp), I-inactive (no death at all)
Fig. 1TLC based chemical screening of lichen extracts. Plate viewed under UV (254 nm). Mobile phase for TLC development was 10% methanol in DCM. W-methanol soluble water fraction, D-DCM fractions. The sample in the TLC plate is as follows: 1, SAR1W; 2, SAR9W; 3, SAR11W; 4, SAR13W; 5, SAR15W; 6, SAR18W; 7, SAR27W; 8, GHAN5W; 9, GHAN8W; 10, GHAN9W; 11, GHAN13W; 12, JOM6W; 13, DAN1W; 14, DAN6W; 15, DAN11W; 16, CHA8W; 17, SAR1D; 18, SAR5D; 19, SAR6D; 20, SAR12D; 21, SAR23D; 22, SAR24D; 23, SAR25D; 24, SAR26D; 25, GHAN5D; 26, GHAN8D; 27, GHAN15D; 28, JOM14D; 29, JOM15D; 23, JOM16D; 31, DAN1D; 32, DAN3D; 33, DAN6D; 34, DAN8D; 35, DAN11D; 36, CHA1D; 37 CHA8D
Fig. 2TLC based antioxidant screening of the active extracts. Mobile phase for TLC development was 10% methanol in DCM. The purple color was from DPPH and antioxidant active fractions showed reduced in purple color to yellow. The darkness of color spots indicated the potential of antioxidant activity, the size of color spot indicated the content of antioxidant active compounds in the extracts. W- methanol soluble water fraction, D- DCM fractions of lichen extracts. The sample in the TLC plate is as follows:1, SAR1W; 2, SAR9W; 3, SAR11W; 4, SAR13W; 5, SAR15W; 6, SAR18W; 7, SAR27W; 8, GHAN5W; 9, GHAN8W; 10, GHAN9W; 11, GHAN13W; 12, JOM6W; 13, DAN1W; 14, DAN6W; 15, DAN11W; 16, CHA8W; 17, SAR1D; 18, SAR5D; 19, SAR6D; 20, SAR12D; 21, SAR23D; 22, SAR24D; 23, SAR25D; 24, SAR26D; 25, GHAN5D; 26, GHAN8D; 27, GHAN15D; 28, JOM14D; 29, JOM15D; 23, JOM16D; 31, DAN1D; 32, DAN3D; 33, DAN6D; 34, DAN8D; 35, DAN11D; 36, CHA1D; 37, CHA8D